Sibel Health closed a $39M Series C extension, bringing total Series C funding to $39M. The extension included strategic investors Maruho Co., Ltd. and Samsung Next and builds on an earlier Series C led by The Steele Foundation for Hope with participation from Dräger.
Comments
Want to join the conversation?
Loading comments...